16.1 Pulmonary Mechanics, Gas Exchange & Acid-Base Regulation

16.1 Pulmonary Mechanics, Gas Exchange & Acid-Base Regulation

Independent Study Guide Notice: Independent study guide by OpenExamPrep. This educational resource is developed independently by OpenExamPrep and is not sponsored, endorsed, or affiliated with the National Board of Podiatric Medical Examiners (NBPME) or Meazure Learning.

---

Introduction to Pulmonary Physiology

Respiration encompasses the integrated physical and chemical processes by which oxygen is extracted from the atmosphere and transported to metabolizing tissues, while carbon dioxide—the terminal end product of cellular aerobic metabolism—is eliminated to maintain systemic acid-base equilibrium. For podiatric physicians, a rigorous mastery of pulmonary mechanics, gas diffusion, ventilation-perfusion matching, and hemoglobin transport is vital. Perioperative risk assessment, general anesthesia induction, postoperative atelectasis, deep vein thrombosis with acute pulmonary embolism, and acid-base disturbances in diabetic ketoacidosis all center directly upon these physiological foundations.

---

Lung Volumes & Capacities

Pulmonary ventilation is quantified through four discrete non-overlapping lung volumes and four composite lung capacities (combinations of two or more volumes):

                         Spirometric Lung Volumes & Capacities

  LUNG VOLUME (mL)
    6000 ┌────────────────────────────────────────────────────────┐ ◄─── TOTAL LUNG
         │                                                        │      CAPACITY (TLC)
         │      Inspiratory Reserve Volume (IRV)                  │      (~6000 mL)
         │               (~3000 mL)                               │
    3000 ├────────────────────────────┬───────────────────────────┤ ◄─── INSPIRATORY
         │    Tidal Volume (TV, 500 mL)│    Vital Capacity (VC)    │      CAPACITY (IC)
    2500 ├────────────────────────────┤         (~4800 mL)        │      (~3500 mL)
         │      Expiratory Reserve    │                           │
         │         Volume (ERV)       │                           │
    1200 ├─────────(~1100 mL)─────────┴───────────────────────────┤ ◄─── FUNCTIONAL RESIDUAL
         │                                                        │      CAPACITY (FRC)
         │      Residual Volume (RV)                              │      (~2300 mL)
       0 └─────────(~1200 mL)─────────────────────────────────────┘
         *(RV, FRC, and TLC CANNOT be measured by standard spirometry)*

The Four Primary Lung Volumes

1. Tidal Volume (TV or $V_T$, ~500 mL): The volume of air inhaled or exhaled with each normal, quiet, spontaneous breath at rest. Of this 500 mL, approximately 350 mL reaches the gas-exchanging alveoli (alveolar ventilation), while roughly 150 mL remains in the non-perfused conducting airways (anatomical dead space, $V_D$).
2. Inspiratory Reserve Volume (IRV, ~3000 mL): The maximal volume of air that can be forcefully inhaled above and beyond the normal tidal volume peak.
3. Expiratory Reserve Volume (ERV, ~1100 mL): The maximal volume of air that can be forcefully exhaled at the end of a normal tidal expiration.
4. Residual Volume (RV, ~1200 mL): The volume of air remaining inside the lungs following a maximal, forceful exhalation. This volume cannot be voluntarily expelled under physiological conditions because the surrounding thoracic cage and small-airway closure prevent total alveolar collapse.

The Four Composite Lung Capacities

1. Inspiratory Capacity (IC, ~3500 mL): $\text{IC} = \text{TV} + \text{IRV}$. The maximal volume of air that can be inspired following a normal tidal expiration.
2. Vital Capacity (VC, ~4800 mL): $\text{VC} = \text{TV} + \text{IRV} + \text{ERV}$. The total volume of gas that can be maximally exhaled following a maximal inhalation. Also termed Forced Vital Capacity (FVC) when exhaled forcefully and rapidly.
3. Functional Residual Capacity (FRC, ~2300 mL): $\text{FRC} = \text{ERV} + \text{RV}$. The volume of gas remaining in the lungs at the end of a normal, passive tidal exhalation.
   • Biomechanical Significance of FRC: FRC represents the resting equilibrium volume of the respiratory system. At FRC, the inward elastic recoil of the lungs is exactly equal and opposite to the outward elastic recoil of the thoracic wall. Consequently, the net distending pressure across the respiratory system is zero, alveolar pressure equals atmospheric pressure ($0 \text{ cmH}_2\text{O}$), and the respiratory muscles are completely relaxed. Intrapleural pressure ($P_{ip}$) at FRC is negative (approximately $-5 \text{ cmH}_2\text{O}$).
4. Total Lung Capacity (TLC, ~6000 mL): $\text{TLC} = \text{TV} + \text{IRV} + \text{ERV} + \text{RV} = \text{VC} + \text{RV} = \text{IC} + \text{FRC}$. The total volume of gas contained within the lungs following a maximal inspiratory effort.

---

Spirometry & Ventilatory Defect Classification

Dynamic spirometry evaluates airflow limitation by recording forced exhalation against time from maximal inspiration (TLC) to maximal exhalation (RV). The three core parameters evaluated are:

• Forced Vital Capacity (FVC): Total volume exhaled forcefully.
• Forced Expiratory Volume in 1 Second ($FEV_1$): Volume exhaled during the first second of the forced maneuver.
• $FEV_1 / FVC$ Ratio: Fraction of total capacity exhaled in the initial second (normal in young adults is $0.75\text{--}0.85$, or $>0.70$ across all ages).

                 Dynamic Spirometry Curves (Volume vs. Time)

  VOLUME (L)
    5.0 ┌────────────────────────────────────────────────────────┐ ◄── Normal FVC (5.0 L)
        │                          ──────────────────────────────┤ ◄── Restrictive FVC (3.2 L)
    4.0 ├───────────/──────────────                              │ ◄── Normal FEV1 (4.0 L)
        │          /                                             │     Normal FEV1/FVC = 0.80
    3.0 ├─────────/                                              │ ◄── Obstructive FVC (3.5 L)
        │        /    /──────────────────────────────────────────┤ ◄── Restrictive FEV1 (2.7 L)
    2.0 ├───────/    /                                           │     Restrictive FEV1/FVC = 0.84
        │      /    /                                            │
    1.0 ├─────/    /                                             │ ◄── Obstructive FEV1 (1.4 L)
        │    /    /                                              │     Obstructive FEV1/FVC = 0.40
      0 └────┴────┴──────────────────────────────────────────────┘
        0    1    2    3    4    5    6    7    8    Time (seconds)
             ▲
             FEV1 Measurement Point (t = 1.0 s)

Obstructive vs. Restrictive Ventilatory Patterns

                     Flow-Volume Loop Morphology

         EXPIRATION (Flow L/s)
             8 ┌                /\
               │               /  \
             6 │              /    \    NORMAL
               │             /      \
             4 │   /\       /        \      OBSTRUCTIVE
               │  /  \     /          \     - "Scooped out" expiratory limb
             2 │ /    \___/            \    - Shifted to left (high volumes)
             0 └───────┴────────────────┴───
               │ \    /\               /
            -2 │  \  /  \             /     RESTRICTIVE
            -4 │   \/    \___________/      - Narrow "witch's hat"
               └────────────────────────────- Normal/elevated FEV1/FVC
               8   7   6   5   4   3   2   1   0  LUNG VOLUME (L)
               High Volumes (TLC)  Low Volumes (RV)

1. Obstructive Lung Diseases (Airway Resistance Elevation):
   • Prototypical Etiologies: Asthma, Chronic Obstructive Pulmonary Disease (COPD: Chronic Bronchitis and Emphysema), Bronchiectasis, Cystic Fibrosis.
   • Pathophysiology: Chronic inflammation, mucosal edema, smooth muscle hypertrophy, or loss of radial traction due to alveolar septal destruction (emphysema) narrows airways. Dynamic airway compression occurs during forced expiration, causing marked flow limitation at low lung volumes.
   • Spirometric Hallmarks:
     • $FEV_1 / FVC < 0.70$ (Definitive diagnostic criterion).
     • $FEV_1$ is markedly reduced; FVC is normal or mildly reduced.
     • Flow-volume loop shows a pathognomonic coved or "scooped-out" expiratory limb.
     • Air Trapping and Hyperinflation: Residual Volume (RV) and Functional Residual Capacity (FRC) are dramatically elevated. Total Lung Capacity (TLC) is increased ($>120\%$ of predicted).
     • Bronchodilator Reversibility Testing: Administration of an inhaled short-acting $\beta_2$-agonist (e.g., albuterol) producing an increase in $FEV_1$ of $>12\%$ AND $>200 \text{ mL}$ demonstrates reversible bronchospasm, confirming the diagnosis of asthma rather than fixed COPD.
2. Restrictive Lung Diseases (Lung Compliance or Chest Wall Limitation):
   • Intrinsic (Parenchymal) Etiologies: Idiopathic Pulmonary Fibrosis (IPF), sarcoidosis, pneumoconioses (asbestosis, silicosis), radiation fibrosis, and drug-induced pulmonary toxicity (bleomycin, amiodarone, busulfan, methotrexate).
   • Extrinsic (Chest Wall & Neuromuscular) Etiologies: Severe kyphoscoliosis, ankylosing spondylitis, pectus excavatum, morbid obesity-hypoventilation syndrome (Pickwickian syndrome), Amyotrophic Lateral Sclerosis (ALS), Myasthenia Gravis, Guillain-Barré syndrome, and phrenic nerve palsy.
   • Pathophysiology: Parenchymal deposition of rigid collagen or mechanical chest wall restriction prevents normal lung expansion, drastically reducing overall pulmonary compliance.
   • Spirometric Hallmarks:
     • $FEV_1 / FVC$ ratio is normal or ELEVATED ($>0.70$, typically $>0.80\text{--}0.85$). Because the stiff radial fibrotic parenchyma pulls small airways open (increased radial traction), expiratory flow rates remain exceptionally high relative to the tiny lung volume.
     • Both $FEV_1$ and FVC are reduced in equal proportion.
     • Total Lung Capacity (TLC) $< 80\%$ of predicted (Definitive gold standard for restrictive diagnosis).
     • Flow-volume loop appears as a miniaturized, narrow, symmetrical "witch's hat" shifted to the right toward lower absolute lung volumes.

---

Pulmonary Mechanics & Surfactant Biophysics

Pressures Governing Respiration & Transpulmonary Pressure

Air moves into and out of the pulmonary tree down hydrostatic pressure gradients established by active respiratory muscle contraction:

• Atmospheric Pressure ($P_{atm}$): Conventionally set to $0 \text{ cmH}_2\text{O}$ as the reference baseline.
• Alveolar Pressure ($P_{alv}$): Pressure within the pulmonary alveoli. During inspiration, $P_{alv}$ drops to $-1 \text{ cmH}_2\text{O}$, drawing air inward. At end-inspiration and end-expiration, airflow ceases and $P_{alv} = 0 \text{ cmH}_2\text{O}$. During active expiration, $P_{alv}$ rises to $+1 \text{ cmH}_2\text{O}$.
• Intrapleural Pressure ($P_{ip}$): Hydrostatic fluid pressure within the potential space between the parietal and visceral pleurae. Under physiological resting conditions, $P_{ip}$ is always negative (subatmospheric), ranging from $-5 \text{ cmH}_2\text{O}$ at FRC to $-8 \text{ cmH}_2\text{O}$ at end-inspiration.
• Transpulmonary Pressure ($P_{tp}$): The distending pressure across the alveolar wall: $P_{tp} = P_{alv} - P_{ip}$ Under all resting physiological conditions, $P_{tp}$ is positive ($0 - [-5] = +5 \text{ cmH}_2\text{O}$), providing the outward mechanical tension that maintains alveolar patency and prevents atelectasis.

Pulmonary Compliance & Elastic Recoil

Compliance ($C = \frac{\Delta V}{\Delta P}$) quantifies the distensibility or ease with which the respiratory structures expand under a given change in transpulmonary distending pressure:

• High Pulmonary Compliance: Seen in pulmonary emphysema. Enzymatic destruction of alveolar elastin by elastase (uninhibited in $\alpha_1$-antitrypsin deficiency or triggered by cigarette smoke) destroys alveolar septa. The lungs lose elastic recoil, become hypercompliant ("floppy"), inflate with minimal effort, but fail to recoil during passive exhalation, causing severe dynamic air trapping.
• Low Pulmonary Compliance: Seen in pulmonary fibrosis, acute respiratory distress syndrome (ARDS), pulmonary edema, and neonatal respiratory distress syndrome. The lungs become exceptionally stiff and non-compliant, requiring massive muscular effort and high transpulmonary pressures to achieve minimal tidal volume expansion.

Pulmonary Surfactant & The Law of Laplace

The physical stability of spherical alveoli lined by a thin aqueous fluid layer is governed by the Law of Laplace for a sphere: $P = \frac{2T}{r}$ Where:

• $P$ is the inward collapsing (distending) pressure exerted on the bubble/alveolus.
• $T$ is the surface tension generated at the air-liquid interface (dynes/cm).
• $r$ is the alveolar radius.

                     Law of Laplace & Surfactant Action

     WITHOUT SURFACTANT: (Uniform Surface Tension T1 = T2)
          P = 2T / r

          Alveolus A (Small, r = 1)         Alveolus B (Large, r = 2)
          Collapsing P = 2(T) / 1 = 2P      Collapsing P = 2(T) / 2 = 1P
          ┌────────┐                        ┌────────────────┐
          │ High P │ ═════════════════════► │  Low Pressure  │
          └────────┘   Air empties into     └────────────────┘
          COLLAPSE /   larger alveolus      OVERDISTENSION
          ATELECTASIS
     ─────────────────────────────────────────────────────────────────
     WITH SURFACTANT: (Dynamic Surface Tension Reduction)
          Surfactant is more concentrated in smaller alveoli (T1 << T2)

          Alveolus A (Small, r = 1)         Alveolus B (Large, r = 2)
          Surface tension lowered to 0.5T   Surface tension remains 1.0T
          P = 2(0.5T) / 1 = 1P              P = 2(1.0T) / 2 = 1P
          ┌────────┐                        ┌────────────────┐
          │ P = 1P │ ◄────────────────────► │     P = 1P     │
          └────────┘    Pressures Equalized └────────────────┘
          STABLE (No Collapse)              STABLE (No Overdistension)

• Biophysical Dilemma: If surface tension ($T$) were constant across all alveoli, smaller alveoli (small radius $r$) would generate a substantially higher collapsing pressure than larger alveoli. Down this pressure gradient, air would empty from small alveoli into adjoining large alveoli, causing catastrophic widespread alveolar collapse (microatelectasis) and concurrent localized overdistension.
• Surfactant Solution: Pulmonary surfactant is synthesized and stored within lamellar bodies by Type II pneumocytes (cuboidal cells comprising ~5% of alveolar surface area that also serve as regenerative stem cells for Type I pneumocytes). The primary surface-active component is dipalmitoylphosphatidylcholine (DPPC / lecithin), a zwitterionic phospholipid assisted by surfactant apoproteins (SP-A, SP-B, SP-C, SP-D).
• Mechanism: Surfactant molecules intersperse among water molecules at the alveolar air-liquid interface, shielding water dipoles and drastically reducing surface tension. Crucially, as an alveolus deflates during exhalation, surfactant molecules are crowded into a tighter packing density, reducing surface tension proportionally more in small alveoli than in large alveoli. This equalizes collapsing pressures across alveoli of varying diameters, prevents end-expiratory atelectasis, and markedly increases overall pulmonary compliance.

Alveolar Gas Exchange & Ventilation-Perfusion Dynamics

The Alveolar Gas Equation

The partial pressure of oxygen within the alveoli ($P_A O_2$) determines the driving gradient for diffusion into pulmonary capillary blood. It is calculated via the Alveolar Gas Equation: $P_A O_2 = P_I O_2 - \frac{P_a CO_2}{R}$ $P_I O_2 = F_I O_2 \times (P_{atm} - P_{H_2O})$ Where:

• $F_I O_2$ is the fraction of inspired oxygen ($0.21$ on room air).
• $P_{atm}$ is barometric pressure ($760 \text{ mmHg}$ at sea level).
• $P_{H_2O}$ is the water vapor pressure at normal body temperature ($47 \text{ mmHg}$ at $37^\circ\text{C}$).
• Thus, inspired oxygen pressure on room air is: $P_I O_2 = 0.21 \times (760 - 47) \approx 150 \text{ mmHg}$.
• $P_a CO_2$ is arterial carbon dioxide partial pressure (normal: $40 \text{ mmHg}$).
• $R$ is the respiratory exchange ratio (metabolic carbon dioxide production divided by oxygen consumption; typically $0.8$ on an average diet).

Substituting standard sea-level values: $P_A O_2 = 150 - \frac{P_a CO_2}{0.8} = 150 - (1.25 \times P_a CO_2)$ At a normal $P_a CO_2$ of $40 \text{ mmHg}$: $P_A O_2 = 150 - (1.25 \times 40) = 150 - 50 = 100 \text{ mmHg}$

The Alveolar-Arterial (A-a) Gradient

The A-a gradient ($P_A O_2 - P_a O_2$) evaluates the functional integrity of the alveolar-capillary gas-exchange membrane:

• Normal A-a Gradient: $< 10\text{--}15 \text{ mmHg}$ in healthy young adults breathing room air. It increases progressively with age (estimated clinically as $\frac{\text{Age}}{4} + 4$). A small normal gradient persists due to physiological right-to-left shunts (thebesian veins draining into the left ventricle and bronchial veins draining into pulmonary veins).
• Hypoxemia with NORMAL A-a Gradient ($< 15 \text{ mmHg}$):
  1. Alveolar Hypoventilation: Respiratory depression from opioid/benzodiazepine overdose, acute brainstem injury, ALS, Guillain-Barré, or flail chest. $P_a CO_2$ rises, which automatically lowers $P_A O_2$ according to the alveolar gas equation. Because the alveolar-capillary barrier is completely normal, arterial $P_a O_2$ drops in exact lockstep with $P_A O_2$, maintaining a normal A-a gradient.
  2. High Altitude: Reduced barometric pressure ($P_{atm}$) lowers inspired $P_I O_2$, reducing $P_A O_2$ and $P_a O_2$ equally.
• Hypoxemia with ELEVATED A-a Gradient ($> 15\text{--}20 \text{ mmHg}$): Signifies intrinsic pulmonary parenchymal or vascular pathology that impairs gas exchange:
  1. Ventilation-Perfusion ($V/Q$) Mismatch: COPD, asthma, localized pulmonary edema, pulmonary embolism.
  2. Anatomical or Physiological Right-to-Left Shunt: Cyanotic congenital heart defects (Tetralogy of Fallot), pulmonary arteriovenous malformations (AVMs), complete alveolar collapse (dense lobar pneumonia, ARDS, massive atelectasis).
  3. Diffusion Limitation: Interstitial pulmonary fibrosis, sarcoidosis, asbestosis.

Regional Ventilation-Perfusion ($V/Q$) Ratios

In an upright individual, gravity exerts a profound hydrostatic influence on both pulmonary ventilation ($V$) and pulmonary capillary perfusion ($Q$):

• Apex (Top of Lung): Both ventilation and perfusion are low compared to the base, but perfusion is disproportionately lower due to low hydrostatic pulmonary arterial pressure. Consequently, the $V/Q \text{ ratio}$ is high (~3.0). Because ventilation greatly exceeds perfusion, local alveolar $P_A O_2$ is high ($130 \text{ mmHg}$) and $P_A CO_2$ is low ($28 \text{ mmHg}$). Clinical Board Correlation: High apical oxygen tension provides the optimal metabolic environment for the reactivation of obligate aerobic Mycobacterium tuberculosis, which characteristically forms cavitary lesions in the lung apices.
• Base (Bottom of Lung): Gravity pulls blood and lung tissue downward, making both ventilation and perfusion highest at the lung bases. However, perfusion increases far more than ventilation. Consequently, the $V/Q \text{ ratio}$ is low (~0.6). Alveolar $P_A O_2$ is lower ($89 \text{ mmHg}$) and $P_A CO_2$ is higher ($42 \text{ mmHg}$).
• Average Global $V/Q$: Across the entire lung, resting alveolar ventilation is ~4.0 L/min and pulmonary blood flow is ~5.0 L/min, yielding an average global $V/Q \approx 0.8$.

                 Ventilation / Perfusion Spectrum

     SHUNT (V/Q = 0)          NORMAL (V/Q = 0.8)       DEAD SPACE (V/Q = ∞)
  ┌─────────────────────┐   ┌─────────────────────┐   ┌─────────────────────┐
  │ Perfused, Unventilated│ │ Matched Gas Exchange│   │ Ventilated, Unperfused│
  │ (Dense consolidation,│  │ PAO2 = 100 mmHg     │   │ (Pulmonary Embolism)│
  │  lobar atelectasis) │   │ PaCO2 = 40 mmHg     │   │ PAO2 = 150 mmHg     │
  │                     │   │                     │   │ PACO2 = 0 mmHg      │
  └──────────┬──────────┘   └──────────┬──────────┘   └──────────┬──────────┘
             │                         │                         │
             ▼                         ▼                         ▼
     Supplemental 100% O2      Supplemental 100% O2       Alveoli act like
     DOES NOT CORRECT          readily corrects           conducting airways;
     hypoxemia (PO2 stays low) hypoxemia                  no gas exchange

• Shunt ($V/Q = 0$): Perfusion occurs in the complete absence of ventilation (e.g., foreign body obstruction, dense consolidation, ARDS). Mixed venous blood bypasses ventilated alveoli and enters systemic circulation completely deoxygenated. Hallmark: Supplemental 100% oxygen ($F_I O_2 = 1.0$) CANNOT correct hypoxemia caused by a true shunt because the administered oxygen cannot reach the perfused alveoli.
• Dead Space ($V/Q = \infty$): Ventilation occurs in the complete absence of capillary perfusion (e.g., acute pulmonary embolism occluding a pulmonary arterial branch). Alveolar gas composition matches inspired air ($P_A O_2 = 150 \text{ mmHg}, P_A CO_2 = 0 \text{ mmHg}$).

Oxygen-Hemoglobin Dissociation & Gas Transport

Cooperativity & The Sigmoidal Curve

Oxygen is transported in the blood in two forms: dissolved in plasma (a tiny fraction: $0.003 \text{ mL } O_2 / 100 \text{ mL blood / mmHg } P_a O_2$) and reversibly bound to the iron ($Fe^{2+}$) atoms of hemoglobin ($Hb$). Hemoglobin is a tetramer of two $\alpha$ and two $\beta$ subunits, each containing a heme prosthetic group. It exhibits positive cooperativity: binding of an initial $O_2$ molecule to one subunit induces a conformational transition from the deoxygenated, low-affinity Tense (T) state to the oxygenated, high-affinity Relaxed (R) state, progressively facilitating the binding of subsequent $O_2$ molecules. This produces the classic sigmoidal (S-shaped) oxygen-hemoglobin dissociation curve.

• $P_{50}$: The partial pressure of oxygen at which hemoglobin is 50% saturated with $O_2$. Normal adult human $P_{50}$ is $27 \text{ mmHg}$. An increase in $P_{50}$ indicates a rightward shift (reduced affinity), while a decrease indicates a leftward shift (increased affinity).

                   Oxygen-Hemoglobin Dissociation Curve

  HEMOGLOBIN SATURATION (%)
    100 ┌──────────────────────────────────── Left Shift (Tighter binding)
        │                            .-─''''─-.
     80 ├─────────────────────────.-'  /   .   '-. Normal Curve (P50 = 27)
        │                      .-'    /   .       '─.
     60 ├────────────────────.'      /   .           '-. Right Shift (Unloading)
        │                  .'       /   .               '─.
     50 ├────────────────-┼────────/───┼───────────────────'-.
        │               .'        /    .                      '-.
     40 ├──────────────'         /     .                         '-.
        │             /         /      .                            '-.
     20 ├───────────.'         /       .                               \
        │          /          /        .                                \
      0 └─────────┴──────────┴─────────┴───────────┴───────────┴─────────┴──
        0         10         20        27          40          60        100
                                       ▲
                             PO2 (mmHg) at Normal P50

Allosteric Effectors: Shifting the Dissociation Curve

          Allosteric Regulators of Oxygen Affinity (CADET Mnemonic)

     RIGHTWARD SHIFT (Reduced Affinity -> Unloading)  ══► CADET Face RIGHT
     - C: Carbon Dioxide (elevated PaCO2)
     - A: Acidosis (elevated [H+], decreased pH) [Bohr Effect]
     - D: 2,3-DPG / 2,3-BPG (elevated levels in RBCs)
     - E: Exercise (muscle produces heat, acid, CO2)
     - T: Temperature (fever, elevated core temperature)
     ─────────────────────────────────────────────────────────────────
     LEFTWARD SHIFT (Increased Affinity -> Tighter Binding)
     - Decreased PaCO2 (hypocapnia)
     - Alkalosis (decreased [H+], elevated pH)
     - Decreased 2,3-BPG levels (banked stored blood)
     - Hypothermia (decreased body temperature)
     - Fetal Hemoglobin (HbF, α2γ2; lacks 2,3-BPG binding site)
     - Carboxyhemoglobin (Carbon monoxide poisoning)
     - Methemoglobin (Fe3+ oxidized heme)

1. Rightward Shift (Enhanced Tissue Oxygen Unloading; Elevated $P_{50}$):
   • Occurs in metabolically active, exercising, or hypoxic tissues where oxygen demand is high.
   • The Bohr Effect: Hydrogen ions bind specific allosteric amino acid residues on deoxyhemoglobin, stabilizing salt bridges that lock hemoglobin in the low-affinity T-state, promoting immediate unloading of oxygen to respiring cells.
   • 2,3-Bisphosphoglycerate (2,3-BPG / DPG): Produced in erythrocytes via the Rapoport-Luebering glycolytic shunt. A single molecule of 2,3-BPG binds into the central cavity of the deoxyhemoglobin tetramer, stabilizing the T-state. 2,3-BPG synthesis increases in response to chronic hypoxia, high altitude, and chronic anemia.
2. Leftward Shift (Inhibited Tissue Unloading; Decreased $P_{50}$):
   • Occurs in the pulmonary capillaries (cooling, $CO_2$ elimination, rising pH) to maximize oxygen loading from alveoli.
   • Pathologically impairs peripheral oxygen delivery: hemoglobin binds oxygen so avidly that it refuses to release it to metabolizing tissues, precipitating tissue cellular hypoxia despite high arterial saturation.
   • Fetal Hemoglobin (HbF, $\alpha_2\gamma_2$): Adult hemoglobin (HbA, $\alpha_2\beta_2$) binds 2,3-BPG via positively charged histidine residues in its $\beta$-chains. The $\gamma$-chains of HbF replace histidine with neutral serine, drastically diminishing 2,3-BPG binding affinity. Consequently, HbF possesses a substantially higher affinity for oxygen than maternal HbA ($P_{50} \approx 19 \text{ mmHg}$), enabling the fetus to extract oxygen across the placenta.

Carbon Monoxide, Methemoglobinemia & Cyanide